Angiogenesis markers quantification in breast cancer and their correlation with clinicopathological prognostic variables.
about
Significance of immunohistochemistry in breast cancerMalignant stroma increases luminal breast cancer cell proliferation and angiogenesis through platelet-derived growth factor signalingQuantitative analysis of 3-Tesla magnetic resonance imaging in the differential diagnosis of breast lesionsEffect of standard chemotherapy and antiangiogenic therapy on plasma markers and endothelial cells in colorectal cancer.The -553 T/A polymorphism in the promoter region of the FGF2 gene is associated with increased breast cancer risk in Polish women.Microvessel density and status of p53 protein as potential prognostic factors for adjuvant anthracycline chemotherapy in retrospective analysis of early breast cancer patients groupBreast tumor and stromal cell responses to TGF-β and hypoxia in matrix deposition.Cadherin-5: a biomarker for metastatic breast cancer with optimum efficacy in oestrogen receptor-positive breast cancers with vascular invasion.Diagnostic Value of Serum Angiogenesis Markers in Ovarian Cancer Using Multiplex ImmunoassayEmerging drugs for the treatment of wound healing.Oncogenic function of angiopoietin-2 in vitro and its modulation of tumor progression in colorectal carcinoma.Sensitive, quantitative, and high-throughput detection of angiogenic markers using shape-coded hydrogel microparticles.Tumor p38MAPK signaling enhances breast carcinoma vascularization and growth by promoting expression and deposition of pro-tumorigenic factors.Emerging roles of endoglin/CD105 and angiogenic cytokines for disease development and progression in multiple myeloma patients.Evidence for novel action at the cell binding site of human Angiogenin revealed by heteronuclear NMR spectroscopy, in silico and in vivo studies.bFGF in tumor tissue independently prognosticates disease outcome of a natural course of invasive breast cancer.Effects of exercise on angiogenesis and apoptosis-related molecules, quality of life, fatigue and depression in breast cancer patients.Impact of early subcultures on stemness, migration and angiogenic potential of adipose tissue-derived stem cells and their resistance to in vitro ischemic condition.VEGF, M-CSF and CA 15-3 as a new tumor marker panel in breast malignancies: a multivariate analysis with ROC curve.Angiogenin outperforms VEGF, EPCs and CECs in predicting Dukes' and AJCC stage in colorectal cancer.Geraniol modulates cell proliferation, apoptosis, inflammation, and angiogenesis during 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis.MicroRNA-542-3p inhibits tumour angiogenesis by targeting angiopoietin-2.Angiopoietin-2 mediates blood-brain barrier impairment and colonization of triple-negative breast cancer cells in brain.Metastatic and triple-negative breast cancer: challenges and treatment optionsA role for FGF2 in visceral adiposity-associated mammary epithelial transformationPDGF‑BB promotes the differentiation and proliferation of MC3T3‑E1 cells through the Src/JAK2 signaling pathwayExpression of angiogenesis regulatory proteins and epithelial-mesenchymal transition factors in platelets of the breast cancer patients
P2860
Q34023682-1C2EE203-7231-4198-ABED-F4D2072952A7Q34309316-353C118E-5C8B-4EAC-99E8-A9CEC9517665Q35048378-5E19B1BD-488B-4041-8A34-BB6F5FDA0E50Q35678109-5D71122E-008D-473D-8043-D994112780E9Q35829182-AC346238-FC46-4A81-8BB9-47AC6C8780A7Q36250209-324C0F0C-B5C9-4514-953A-4BBD02AD515AQ36736295-E11E5945-26E0-4186-8ABB-C3896E1EDA5AQ37175071-ABA2E7FF-096C-415C-8165-05098A30011BQ37631567-40C04D2D-DDAF-4D69-A0BA-F2C7795FA13CQ38364058-C3D8B9A6-D91E-4846-8960-D5B525AF9BB0Q38697673-72CC6457-CD96-4589-A636-4939E1B9885BQ38873232-62C09AE0-CF9B-4868-977C-173EA4A27DD5Q42252540-8EC42D0A-C0E0-4B39-A8AF-C724C9F2FCE8Q43864995-CF2D5964-D1BF-4215-BBBA-7E8F71C93D70Q47190885-E2F52541-2D85-47C7-8B71-52940488FAE3Q47966264-56752355-F306-46E4-8DAA-01E53152A2F6Q48232163-4952A358-11D9-46F2-A13C-CA6840BFA0BFQ50865379-95DD7286-A2C3-4532-BBAB-9F402E8A4433Q50979907-CDB78245-BB46-457C-A9D6-EEBF9BEF0DC9Q50986069-F20F005A-7BB8-4A50-97A6-4D2C133F485DQ51758114-2680F9C3-4099-45B8-8C81-026FE4652F2AQ51760093-D134B45C-D99D-44A4-BC04-AAA6F51B1BA8Q52646854-63AA9A95-F8D9-4736-A0EE-1498C8B03A25Q57105258-882A6DAE-9E02-46F1-99A6-06A045794FA3Q58156984-1FF62161-3554-4066-B48C-52F00983EE18Q58800907-0D267A67-03A3-47B1-8C98-D8B6D6B31A29Q59101144-EBA0795F-F87A-4A12-B649-9CC66634A82F
P2860
Angiogenesis markers quantification in breast cancer and their correlation with clinicopathological prognostic variables.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Angiogenesis markers quantific ...... ological prognostic variables.
@ast
Angiogenesis markers quantific ...... ological prognostic variables.
@en
type
label
Angiogenesis markers quantific ...... ological prognostic variables.
@ast
Angiogenesis markers quantific ...... ological prognostic variables.
@en
prefLabel
Angiogenesis markers quantific ...... ological prognostic variables.
@ast
Angiogenesis markers quantific ...... ological prognostic variables.
@en
P2093
P2860
P1476
Angiogenesis markers quantific ...... ological prognostic variables.
@en
P2093
Adam Dziki
Andrzej Sygut
Grazyna Pasz-Walczak
Ireneusz Majsterek
Jan Rykala
Julia Kruk-Jeromin
Karolina Przybylowska
P2860
P2888
P304
P356
10.1007/S12253-011-9387-6
P577
2011-05-11T00:00:00Z